StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.90+0.05 (+5.86%)

Close on Nov 20, 2026Market cap $7.26MP/E –Yield –

Immuron gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2026 it was A$4.98M, up 4.4% from the year before. Over ten years it grew 21.7% a year on average. The highest annual figure on record is A$4.98M in fiscal 2026.

Annual gross profit

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$4.98M+4.4%
FY2025Jun 30, 2025A$4.77M+42.8%
FY2024Jun 30, 2024A$3.34M+154.9%
FY2023Jun 30, 2023A$1.31M+150.1%
FY2022Jun 30, 2022A$523.50K+452.8%
FY2021Jun 30, 2021A$94.71K-94.8%
FY2020Jun 30, 2020A$1.83M+6.4%
FY2019Jun 30, 2019A$1.72M+20.8%
FY2018Jun 30, 2018A$1.42M+34.5%
FY2017Jun 30, 2017A$1.06M+51.3%
FY2016Jun 30, 2016A$699.64K–

More Immuron figures

See a number that looks wrong?